申请人:Sanofi-Aventis
公开号:EP2138492A1
公开(公告)日:2009-12-30
A pyrimidone derivative represented by formula (I) or a salt thereof, or a solvate thereof or a hydrate thereof:
Y represents two hydrogen atoms, a sulphur atom, an oxygen atom, an hydroxy group and a hydrogen atom, an hydroxy group and a C1-2 alkyl group, an hydroxy group and a C1-2 perhalogenated alkyl group; a halogen atom and a hydrogen atom or a -(CH2)p-;Z represents a bond, an oxygen atom, NH, a nitrogen atom substituted by a hydrogen atom or a C1-3 alkyl group, a sulphur atom, a methylene group optionally substituted ; R1 represents a 2, 3 or 4-pyridine ring or a 2, 4 or 5-pyrimidine ring, the ring being optionally substituted; R2 represents a hydrogen atom, a C1-6 alkyl group or a halogen atom; R3 represents a hydrogen atom; a phenyl or a naphthyl group, these groups being optionally substituted a 4-15 membered heterocyclic group optionally substituted a -C(O)O (C1-6-alkyl) group optionally substituted ; a -C(O)-phenyl group, a -C(O)O-phenyl group, or a - C(O)O-CH2-phenyl group,the benzene rings of the above-mentioned groups being optionally substituted ; a -C(O)-4-15 membered heterocyclic group optionally substituted; R4 represents a hydrogen atom, a halogen atom, a hydroxyl group, a C1-6 alkyl group optionally substituted; n represents 0 to 3; m represents 0 to 3 ; p represents 2 to 7; in the form of a free base or of an addition salt with an acid. Use in therapeutic
由以下化学式(I)代表的嘧啶酮衍生物或其盐,或其溶剂合物或水合物:Y代表两个氢原子,一个硫原子,一个氧原子,一个羟基和一个氢原子,一个羟基和一个C1-2烷基基团,一个羟基和一个C1-2全氟烷基基团;一个卤素原子和一个氢原子或一个-(CH2)p-;Z代表一个键,一个氧原子,NH,一个氮原子,被氢原子或C1-3烷基基团取代,一个硫原子,一个甲基基团,可选择地取代;R1代表一个2、3或4-吡啶环或一个2、4或5-嘧啶环,该环可选择地取代;R2代表一个氢原子,一个C1-6烷基基团或一个卤素原子;R3代表一个氢原子;一个苯基或一个萘基,这些基团可选择地取代一个4-15成员杂环基团,可选择地取代一个-C(O)O(C1-6-烷基)基团;一个-C(O)-苯基团,一个-C(O)O-苯基团,或一个-C(O)O-CH2-苯基团,上述基团的苯环可选择地取代;一个-C(O)-4-15成员杂环基团,可选择地取代;R4代表一个氢原子,一个卤素原子,一个羟基,一个可选择地取代的C1-6烷基基团;n代表0到3;m代表0到3;p代表2到7;以自由碱或与酸形成的加合盐形式。在治疗中的用途。